{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:25:24Z","timestamp":1782865524269,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.ophtha.2005.10.067","type":"journal-article","created":{"date-parts":[[2006,4,5]],"date-time":"2006-04-05T10:46:34Z","timestamp":1144233994000},"page":"684-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Risk of Immune Recovery Uveitis in Patients with AIDS and Cytomegalovirus Retinitis"],"prefix":"10.1016","volume":"113","author":[{"given":"John H.","family":"Kempen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-I.","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary N.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy N.","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas T.","family":"Dieterich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2005.10.067_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib2","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1097\/00002030-200011100-00023","article-title":"Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS","volume":"14","author":"Baril","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2005.10.067_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/00002030-200006160-00013","article-title":"Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy","volume":"14","author":"Deayton","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2005.10.067_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2005.10.067_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2005.10.067_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1023\/A:1007619323939","article-title":"The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy","volume":"16","author":"Varani","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10096-004-1160-2","article-title":"Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe","volume":"23","author":"Yust","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ophtha.2005.10.067_bib8","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ophtha.2004.05.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. 1. Retinitis progression","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.10.067_bib9","first-page":"33","article-title":"Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome","volume":"119","author":"Kempen","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib10","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2004.05.028","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. 2. Second eye involvement and retinal detachment","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.10.067_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archopht.121.4.466","article-title":"Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome","volume":"121","author":"Kempen","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib12","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1086\/379077","article-title":"Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome","volume":"37","author":"Kempen","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2005.10.067_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1469-0691.2000.00009.x","article-title":"Retrospective study of CMV retinitis in patients with AIDS","volume":"6","author":"Pauriah","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ophtha.2005.10.067_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1258\/0956462011923886","article-title":"Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis","volume":"12","author":"Skiest","year":"2001","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ophtha.2005.10.067_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00002030-199806000-00010","article-title":"Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors","volume":"12","author":"Walsh","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2005.10.067_bib16","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/bjo.87.7.853","article-title":"Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy","volume":"87","author":"Goldberg","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archopht.116.2.169","article-title":"Immune recovery vitritis associated with inactive cytomegalovirus retinitis","volume":"116","author":"Karavellas","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1086\/314639","article-title":"Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy","volume":"179","author":"Karavellas","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2005.10.067_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9394(00)00528-6","article-title":"Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis","volume":"130","author":"Karavellas","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9394(00)00356-1","article-title":"Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy","volume":"129","author":"Nguyen","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9394(00)00530-4","article-title":"Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy","volume":"130","author":"Robinson","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0002-9394(03)00335-0","article-title":"Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis","volume":"136","author":"Song","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0002-9394(99)80134-2","article-title":"Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis","volume":"125","author":"Zegans","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200102000-00001","article-title":"Immune recovery vitritis and uveitis in AIDS","volume":"21","author":"Karavellas","year":"2001","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2005.10.067_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/bjo.83.5.540","article-title":"Treatment of immune recovery vitritis with local steroids","volume":"83","author":"Henderson","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00006982-200308000-00009","article-title":"Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela","volume":"23","author":"Arevalo","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2005.10.067_bib27","first-page":"636","article-title":"Valganciclovir therapy for immune recovery uveitis complicated by macular edema","volume":"137","author":"Kosobucki","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(01)01322-8","article-title":"Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"133","author":"Jabs","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0161-6420(03)00089-7","article-title":"The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy","volume":"110","author":"Kempen","year":"2003","journal-title":"Ophthalmology"},{"issue":"RR-17","key":"10.1016\/j.ophtha.2005.10.067_bib30","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ophtha.2005.10.067_bib31","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2005.10.067_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archopht.119.4.554","article-title":"Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients","volume":"119","author":"Holbrook","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib33","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/archopht.1989.01070020841024","article-title":"A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome","volume":"107","author":"Holland","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9394(82)90197-0","article-title":"New visual acuity charts for clinical research","volume":"94","author":"Ferris","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0197-2456(92)90027-W","article-title":"Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods","volume":"13","year":"1992","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ophtha.2005.10.067_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0161-6420(96)30742-2","article-title":"Standardizing the measurement of visual acuity for clinical research studies","volume":"103","author":"Ferris","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2005.10.067_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0002-9394(82)90198-2","article-title":"Standardized illumination for visual acuity testing in clinical research","volume":"94","author":"Ferris","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0002-9394(99)80149-4","article-title":"Human immunodeficiency virus disease","volume":"125","author":"Nussenblatt","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib39","series-title":"Primer on the Rheumatic Diseases","first-page":"1","article-title":"The social and economic consequences of rheumatic disease","author":"Callahan","year":"2001"},{"key":"10.1016\/j.ophtha.2005.10.067_bib40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archopht.1997.01100150735008","article-title":"Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis","volume":"115","author":"Davis","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib41","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/00002030-200007280-00013","article-title":"Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis","volume":"14","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2005.10.067_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9394(01)00840-6","article-title":"The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome","volume":"131","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib43","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/jama.283.5.653","article-title":"Cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"283","author":"Whitcup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2005.10.067_bib44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9394(00)00537-7","article-title":"Immune recovery uveitis","volume":"130","author":"Kuppermann","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2005.10.067_bib45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1310\/4J65-4YX1-4ET6-E5KR","article-title":"The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy","volume":"6","author":"Wohl","year":"2005","journal-title":"HIV Clin Trials"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200600073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200600073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:49:42Z","timestamp":1758980982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164200600073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S016164200600073X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2005.10.067","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Immune Recovery Uveitis in Patients with AIDS and Cytomegalovirus Retinitis","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2005.10.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}